Back
Voyager Therapeutics 10K Form
Sell
21
VYGR
Voyager Therapeutics
Last Price:
$3.90
Seasonality Move:
11.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VYGR News And Ratings
See the #1 stock for the next 7 days that we like better than VYGR
VYGR Financial Statistics
Sales & Book Value
| Annual Sales: | $80M |
|---|---|
| Cash Flow: | $-14.7M |
| Price / Cash Flow: | 50.49 |
| Annual Sales: | $5.48 |
| Price / Book: | 0.72 |
Profitability
| EPS (TTM): | -1.13000 |
|---|---|
| Net Income (TTM): | $-65M |
| Gross Margin: | -- |
| Return on Equity: | -21.07% |
| Return on Assets: | -15.65% |
Voyager Therapeutics Earnings Forecast
Key Voyager Therapeutics Financial Ratios
-
The Research & Development expenses have been 159.21% of Revenue.
-
The Net Earning history of VYGR is -81.25% of Total Revenues.
-
Per Share Earnings over the last 11 years have been positive in 5 years.
Voyager Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VYGR |
| CUSIP: | 92915B |
| Website: | voyagertherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.56 |
| Quick Ratio: | 5.45 |
Price-to-Earnings
| Trailing P/E Ratio: | 1.34 |
|---|---|
| Forward P/E Ratio: | 0 |
VYGR Technical Analysis vs Fundamental Analysis
Sell
21
Voyager Therapeutics (VYGR)
is a Sell
Is Voyager Therapeutics a Buy or a Sell?
-
Voyager Therapeutics stock is rated a SellThe current Voyager Therapeutics [VYGR] share price is $3.90. The Score for VYGR is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.